RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: lupus nephritis
Accession: DOID:0080162
browse the term
Definition: A glomerulonephritis that is characterized by inflammation of the kidneys resulting from systemic lupus erythematosus. (DO)
Synonyms: exact_synonym: Lupus Glomerulonephritides; Lupus Glomerulonephritis; Lupus Nephritides; SLE nephritis; Systemic Lupus Erythematosus with Nephritis
related_synonym: SLEN1; SLEN2; SLEN3; Systemic Lupus Erythematosus with Nephritis, Susceptibility To, 1; Systemic Lupus Erythematosus with Nephritis, Susceptibility To, 2; Systemic Lupus Erythematosus with Nephritis, Susceptibility To, 3; lupus nephritis, susceptibility to
primary_id: MESH:D008181
alt_id: DOID:9004124
xref: EFO:0005761 ; GARD:10747 ; MIM:607965 ; MIM:607966 ; MIM:607967
G
Ager
advanced glycosylation end product-specific receptor
ISO
DNA:polymorphisms:promoter, intron:g.-429T>C rs1800625, g.-374T>A rs1800624, g.2184A>G rs3134940 (human)
RGD
PMID:22513366
RGD:6767309
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Apoc3
apolipoprotein C-III
ISO
protein:increased expression:serum
RGD
PMID:17957542
RGD:7207211
NCBI chr 9:46,144,348...46,146,934
Ensembl chr 9:46,144,231...46,146,934
G
C3
complement component 3
ISO
protein:decreased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:31182691 PMID:21888025
RGD:7175544
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Ccl2
C-C motif chemokine ligand 2
severity susceptibility
ISO
protein:increased expression:urine (human) DNA:snp:promoter:g.-2518A>G (human)
RGD
PMID:8558841 PMID:15188361
RGD:8549732 , RGD:11528534
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl3
C-C motif chemokine ligand 3
IEP
RGD
PMID:18187931
RGD:7241814
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
G
Ccr1
C-C motif chemokine receptor 1
disease_progression
IMP
RGD
PMID:15153561
RGD:5688164
NCBI chr 9:123,762,163...123,768,729
Ensembl chr 9:123,762,161...123,768,729
G
Cd40
CD40 antigen
treatment
IMP IDA
RGD
PMID:23799000 PMID:19265127 PMID:18566369
RGD:7248418 , RGD:7248425 , RGD:7248429
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cd40lg
CD40 ligand
treatment
ISO IMP IDA
protein:increased expression:serum
RGD
PMID:20726330 PMID:15693003 PMID:13130474 PMID:12632425 PMID:11751940
RGD:7248426 , RGD:7248439 , RGD:7248600 , RGD:7248710 , RGD:7248714
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
G
Cfb
complement factor B
IMP ISO IEP
RGD
PMID:10623824 PMID:21893562 PMID:3183062
RGD:7242736 , RGD:7242755 , RGD:7242763
NCBI chr17:35,075,350...35,081,492
Ensembl chr17:35,075,350...35,081,494
G
Cfh
complement component factor h
ISO
RGD
PMID:22171659
RGD:5684551
NCBI chr 1:140,013,593...140,111,149
Ensembl chr 1:140,012,446...140,111,502
G
Clu
clusterin
IEP
mRNA:increased expression: epithelial cell of renal tubule
RGD
PMID:9546356
RGD:8890679
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
G
Col1a1
collagen, type I, alpha 1
ISO IEP IDA
mRNA, protein:increased expression:kidney cortex associated with Graft vs Host Disease
RGD
PMID:21354048 PMID:7723234 PMID:7700025
RGD:5688301 , RGD:5688332 , RGD:5688333
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
Crp
C-reactive protein, pentraxin-related
no_association
ISO
DNA:SNP
RGD
PMID:18852001 PMID:15692982 PMID:20039408 PMID:17596285
RGD:6907400 , RGD:6909145 , RGD:6909146 , RGD:5508454
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Csf1
colony stimulating factor 1 (macrophage)
IMP ISO
RGD
PMID:21885670 PMID:17659436
RGD:7257567 , RGD:7257589
NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
RGD
PMID:15146424
RGD:7204726
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
G
Egf
epidermal growth factor
ISO
RGD
PMID:21354048
RGD:5688301
NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
G
Fas
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33632240 PMID:38555047
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fcgr2b
Fc receptor, IgG, low affinity IIb
IMP
RGD
PMID:15681388
RGD:7240529
NCBI chr 1:170,786,186...170,804,141
Ensembl chr 1:170,786,186...170,804,116
G
Fcgr3
Fc receptor, IgG, low affinity III
ISO
DNA:missense mutation:cds:p.H131R (human)
RGD
PMID:15004265
RGD:5147975
NCBI chr 1:170,878,738...170,893,477
Ensembl chr 1:170,878,743...170,892,504
G
Fcgr4
Fc receptor, IgG, low affinity IV
susceptibility
ISO
DNA:SNP:cds:p.V158F (human)
RGD
PMID:17596285
RGD:5508454
NCBI chr 1:170,846,495...170,857,330
Ensembl chr 1:170,846,489...170,857,330
G
H2-Aa
histocompatibility 2, class II antigen A, alpha
susceptibility
ISO
DNA:polymorphisms:cds:HLA-DQA1*0101 (human) DNA:polymorphisms:cds:HLA-DQA1*0102 (human)
RGD
PMID:12651073
RGD:40902999
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
G
H2-Eb1
histocompatibility 2, class II antigen E beta
susceptibility
ISO
DNA:polymorphisms:cds:HLA-DRB1*1501 (human)
RGD
PMID:12651073
RGD:40902999
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
G
Ifng
interferon gamma
ISO
protein:increased expression:serum,urine protein:increased processing:kidney CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:31182691 PMID:22764573 PMID:29925830
RGD:6893369 , RGD:14974252
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Il17a
interleukin 17A
treatment
IDA
RGD
PMID:25129462
RGD:9244623
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il18
interleukin 18
IEP
RGD
PMID:20980973
RGD:6893449
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il1b
interleukin 1 beta
IDA IEP
mRNA:increased expression:renal glomerulus (mouse)
RGD
PMID:21641991 PMID:20410215
RGD:7175315 , RGD:7175344
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
resistance
ISO
associated with Lupus Erythematosus, Systemic; protein:increased expression:serum (human)
RGD
PMID:20538031
RGD:6907068
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Itgam
integrin alpha M
ISO
RGD
PMID:21719445
RGD:5147916
NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663
G
Jak1
Janus kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31182691
NCBI chr 4:101,009,171...101,122,493
Ensembl chr 4:101,009,564...101,122,479
G
Klkb1
kallikrein B, plasma 1
susceptibility
ISO
DNA:SNPs:promoter:
RGD
PMID:19307730
RGD:7327150
NCBI chr 8:45,719,725...45,747,872
Ensembl chr 8:45,719,726...45,747,896
G
Mbl2
mannose-binding lectin (protein C) 2
disease_progression
ISO
DNA:polymorphism:exon:
RGD
PMID:24850777
RGD:12910847
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
G
Mir125a
microRNA 125a
ISO
RNA:decreased expression:kidney
RGD
PMID:30972208
RGD:26884458
NCBI chr17:18,051,074...18,051,141
Ensembl chr17:18,051,074...18,051,141
G
Mmp2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22479529
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22479529
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mpo
myeloperoxidase
susceptibility
ISO
DNA:polymorphism: :−463G > A (human)
RGD
PMID:17896805
RGD:7174701
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Mtor
mechanistic target of rapamycin kinase
IMP
RGD
PMID:17283580
RGD:7245502
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Muc20
mucin 20
IEP
RGD
PMID:14565953
RGD:7364790
NCBI chr16:32,597,793...32,617,805
Ensembl chr16:32,597,793...32,617,805
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
IEP ISO
RGD
PMID:21509671 PMID:17880936
RGD:7174713 , RGD:7174734
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Otub1
OTU domain, ubiquitin aldehyde binding 1
ISO
protein:increased expression:kidney
RGD
PMID:22279542
RGD:7175260
NCBI chr19:7,175,571...7,183,649
Ensembl chr19:7,175,567...7,183,681
G
Pdcd1
programmed cell death 1
onset
ISO IMP
DNA:polymorphism: : DNA:polymorphism:intron:6867 C>T (human)
RGD
PMID:15934088 PMID:15352422 PMID:21041733
RGD:7248675 , RGD:7248676 , RGD:7248678
NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278
G
Sell
selectin, lymphocyte
IEP
RGD
PMID:20512127
RGD:7175284
NCBI chr 1:163,889,556...163,908,354
Ensembl chr 1:163,889,551...163,911,750
G
Serping1
serine (or cysteine) peptidase inhibitor, clade G, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:4014294
NCBI chr 2:84,595,704...84,605,748
Ensembl chr 2:84,595,731...84,605,788
G
Snrpe
small nuclear ribonucleoprotein E
treatment
IDA
mouse model
RGD
PMID:15494537
RGD:10760401
NCBI chr 1:133,531,609...133,538,018
Ensembl chr 1:133,531,609...133,538,029
G
Stat1
signal transducer and activator of transcription 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31182691
NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024
G
Stat4
signal transducer and activator of transcription 4
IMP
RGD
PMID:20980973
RGD:6893449
NCBI chr 1:52,026,265...52,146,348
Ensembl chr 1:52,026,307...52,146,348
G
Stat6
signal transducer and activator of transcription 6
disease_progression
IMP
RGD
PMID:12874250
RGD:7244140
NCBI chr10:127,478,855...127,496,856
Ensembl chr10:127,478,855...127,496,826
G
Tlr7
toll-like receptor 7
IMP
RGD
PMID:19944565
RGD:7246905
NCBI chr X:166,086,376...166,113,570
Ensembl chr X:166,087,925...166,113,554
G
Tlr9
toll-like receptor 9
no_association treatment severity
IMP ISO IDA IEP
DNA:snps:intron, exon:g.+1174G>A, g.+1635C>T (rs352139, rs352140) (human, Chinese) associated with Lupus Erythematosus, Systemic; DNA:snps:promoter, intron:g.-1486T>C, g.+1174A>G (rs187084, rs352139) (human, North Indian) protein:increased expression:renal glomerulus (human) associated with Graft vs Host Disease mRNA, protein:increased expression:kidney (mouse)
RGD
PMID:23467932 PMID:20497632 PMID:22787315 PMID:19578108 PMID:21127878 PMID:17469139 More...
RGD:7245987 , RGD:7246884 , RGD:7245989 , RGD:7246896 , RGD:7246897 , RGD:7246911
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:glomerular mesangial cell
RGD
PMID:7750940
RGD:7394786
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf11b
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)
ISO
associated with Lupus Erythematosus, Systemic;protein:increased expression:urine
RGD
PMID:21691937
RGD:7205483
NCBI chr15:54,114,014...54,141,700
Ensembl chr15:54,114,015...54,141,880
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
severity
IGI ISO
RGD
PMID:19201910 PMID:10906156
RGD:7245569 , RGD:7245572
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Tnfrsf1b
tumor necrosis factor receptor superfamily, member 1b
treatment
ISO IDA
RGD
PMID:22846145 PMID:22674120
RGD:7245541 , RGD:7245544
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
G
Vcam1
vascular cell adhesion molecule 1
severity
ISO
protein:increased expression:urine
RGD
PMID:22788914
RGD:7241032
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all